Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Preparation and Evaluation of Atorvastatin-Loaded Nanoemulgel on Wound-Healing Efficacy.

Morsy MA, Abdel-Latif RG, Nair AB, Venugopala KN, Ahmed AF, Elsewedy HS, Shehata TM.

Pharmaceutics. 2019 Nov 13;11(11). pii: E609. doi: 10.3390/pharmaceutics11110609.

2.

Novel Series of Methyl 3-(Substituted Benzoyl)-7-Substituted-2-Phenylindolizine-1-Carboxylates as Promising Anti-Inflammatory Agents: Molecular Modeling Studies.

Venugopala KN, Al-Attraqchi OHA, Tratrat C, Nayak SK, Morsy MA, Aldhubiab BE, Attimarad M, Nair AB, Sreeharsha N, Venugopala R, Haroun M, Girish MB, Chandrashekharappa S, Alwassil OI, Odhav B.

Biomolecules. 2019 Oct 28;9(11). pii: E661. doi: 10.3390/biom9110661.

3.

Protective Effect of Spirulina platensis Extract against Dextran-Sulfate-Sodium-Induced Ulcerative Colitis in Rats.

Morsy MA, Gupta S, Nair AB, Venugopala KN, Greish K, El-Daly M.

Nutrients. 2019 Sep 29;11(10). pii: E2309. doi: 10.3390/nu11102309.

4.

Computational and Biological Comparisons of Plant Steroids as Modulators of Inflammation through Interacting with Glucocorticoid Receptor.

Morsy MA, Patel SS, El-Sheikh AAK, Savjani JK, Nair AB, Shah JN, Venugopala KN.

Mediators Inflamm. 2019 May 27;2019:3041438. doi: 10.1155/2019/3041438. eCollection 2019.

5.

Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.

Venugopala KN, Chandrashekharappa S, Pillay M, Abdallah HH, Mahomoodally FM, Bhandary S, Chopra D, Attimarad M, Aldhubiab BE, Nair AB, Sreeharsha N, Morsy MA, Pottathil S, Venugopala R, Odhav B, Mlisana K.

PLoS One. 2019 Jun 4;14(6):e0217270. doi: 10.1371/journal.pone.0217270. eCollection 2019.

6.

Modulation of eNOS/iNOS by nebivolol protects against cyclosporine A-mediated nephrotoxicity through targeting inflammatory and apoptotic pathways.

El-Sheikh AAK, Morsy MA, Abdel-Latif RG.

Environ Toxicol Pharmacol. 2019 Jul;69:26-35. doi: 10.1016/j.etap.2019.03.018. Epub 2019 Mar 21.

PMID:
30927701
7.
8.

Prevention of rat liver fibrosis by selective targeting of hepatic stellate cells using hesperidin carriers.

Morsy MA, Nair AB.

Int J Pharm. 2018 Dec 1;552(1-2):241-250. doi: 10.1016/j.ijpharm.2018.10.003. Epub 2018 Oct 3.

PMID:
30291958
9.

Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.

Venugopala KN, Chandrashekharappa S, Pillay M, Bhandary S, Kandeel M, Mahomoodally FM, Morsy MA, Chopra D, Aldhubiab BE, Attimarad M, Alwassil OI, Harsha S, Mlisana K, Odhav B.

Med Chem. 2019;15(3):311-326. doi: 10.2174/1573406414666180703121815.

PMID:
29968540
10.

The effect of adjuvant therapy with TNF-α on animal model of triple-negative breast cancer.

Greish K, Taurin S, Morsy MA.

Ther Deliv. 2018 May;9(5):333-342. doi: 10.4155/tde-2017-0101.

PMID:
29681232
11.

In silico comparisons between natural inhibitors of ABCB1/P-glycoprotein to overcome doxorubicin-resistance in the NCI/ADR-RES cell line.

Morsy MA, El-Sheikh AAK, Ibrahim ARN, Khedr MA, Al-Taher AY.

Eur J Pharm Sci. 2018 Jan 15;112:87-94. doi: 10.1016/j.ejps.2017.11.010. Epub 2017 Nov 11.

PMID:
29133241
12.

Inhibition of NF-κB/TNF-α pathway may be involved in the protective effect of resveratrol against cyclophosphamide-induced multi-organ toxicity.

El-Sheikh AA, Morsy MA, Okasha AM.

Immunopharmacol Immunotoxicol. 2017 Aug;39(4):180-187. doi: 10.1080/08923973.2017.1318913. Epub 2017 May 2.

PMID:
28463035
13.

Protective mechanisms of resveratrol against methotrexate-induced renal damage may involve BCRP/ABCG2.

El-Sheikh AA, Morsy MA, Al-Taher AY.

Fundam Clin Pharmacol. 2016 Oct;30(5):406-18. doi: 10.1111/fcp.12205. Epub 2016 Jun 21.

PMID:
27213989
14.

Quantitative determination of copper in a glass matrix using double pulse laser induced breakdown and electron paramagnetic resonance spectroscopic techniques.

Khalil AA, Morsy MA.

Talanta. 2016 Jul 1;154:109-18. doi: 10.1016/j.talanta.2016.03.031. Epub 2016 Mar 12.

PMID:
27154655
15.

Protective Mechanisms of Thymoquinone on Methotrexate-induced Intestinal Toxicity in Rats.

El-Sheikh AA, Morsy MA, Hamouda AH.

Pharmacogn Mag. 2016 Jan;12(Suppl 1):S76-81. doi: 10.4103/0973-1296.176106.

16.

Nebivolol Ameliorates Cisplatin-Induced Nephrotoxicity in Rats.

Morsy MA, Heeba GH.

Basic Clin Pharmacol Toxicol. 2016 Jun;118(6):449-55. doi: 10.1111/bcpt.12538. Epub 2016 Jan 14.

17.

Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease.

Heeba GH, Morsy MA.

Environ Toxicol Pharmacol. 2015 Nov;40(3):907-14. doi: 10.1016/j.etap.2015.10.003. Epub 2015 Oct 23.

PMID:
26498267
18.

Mechanisms of Thymoquinone Hepatorenal Protection in Methotrexate-Induced Toxicity in Rats.

El-Sheikh AA, Morsy MA, Abdalla AM, Hamouda AH, Alhaider IA.

Mediators Inflamm. 2015;2015:859383. doi: 10.1155/2015/859383. Epub 2015 May 21.

19.

Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats.

Morsy MA, Heeba GH, Mahmoud ME.

Eur J Pharmacol. 2015 Mar 5;750:90-7. doi: 10.1016/j.ejphar.2015.01.027. Epub 2015 Jan 24. Erratum in: Eur J Pharmacol. 2015 Sep 5;762:487.

PMID:
25625658
20.

Multi-drug resistance protein (Mrp) 3 may be involved in resveratrol protection against methotrexate-induced testicular damage.

El-Sheikh AA, Morsy MA, Al-Taher AY.

Life Sci. 2014 Dec 5;119(1-2):40-6. doi: 10.1016/j.lfs.2014.10.015. Epub 2014 Oct 30.

PMID:
25445225

Supplemental Content

Loading ...
Support Center